Crystal Research Associates was established in 2003 in response to the growing need for independent equity research and innovative thinking in today's highly competitive markets. Founders Jeffrey Kraws and Karen Goldfarb are veteran Wall Street sell-side analysts who recognized the need for independent research that is 100% factual and free of subjective opinions or projections stemming from potential conflicts of interest.
Working as a team since 1995, Kraws and Goldfarb are well known and highly respected on Wall Street and by the international financial media for providing consistent award-winning analyses and developing long-term relationships on both the buy-side and sell-side.
Since its establishment, Crystal Research Associates has quickly gained broad recognition among professional investors and its clientele as a quality provider of innovative, fact-driven research that reaches a wide spectrum of stakeholders and fund managers. In a relatively brief period, Kraws and Goldfarb have built a portfolio of diverse clients and produced a library of well-received research reports, contributing to Crystal Research Associates' fast-growing credibility throughout the industry.
Number one among all pharmaceutical analysts for stock performance in 2001 - Starmine.com